Silverio Tomao

Pubblicazioni

Titolo Pubblicato in Anno
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study BIOMARKER RESEARCH 2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial SCIENTIFIC REPORTS 2021
Circulating hpv dna in the management of oropharyngeal and cervical cancers: Current knowledge and future perspectives JOURNAL OF CLINICAL MEDICINE 2021
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience THE BREAST JOURNAL 2021
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study BIOMARKER RESEARCH 2021
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence JOURNAL OF CELLULAR PHYSIOLOGY 2020
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens COMMUNICATIONS BIOLOGY 2020
Expression of er, pgr, her-2, and ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy CANCER CHEMOTHERAPY AND PHARMACOLOGY 2020
Fertility and reproduction in breast cancer patients BREAST CANCER RESEARCH AND TREATMENT 2020
Expanding use of rucaparib as maintenance therapy in recurrent ovarian cancer: updates from the ARIEL3 trial THE LANCET ONCOLOGY 2020
Metachronous and synchronous cancers in patients with neuroendocrine tumors ONCOLOGY 2020
The 5-Ws of immunotherapy in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2020
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 2020
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials CANCERS 2020
Oncotype DX predictive nomogram for recurrence score output: the novel system ADAPTED01 based on quantitative immunochemistry analysis CLINICAL BREAST CANCER 2020
Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy MOLECULAR AND CLINICAL ONCOLOGY 2019
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: efficacy and safety in clinical practice ONCOLOGY LETTERS 2019
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: a real-world experience JOURNAL OF CELLULAR PHYSIOLOGY 2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting INTERNATIONAL JOURNAL OF CANCER 2019

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma